Our history already spans more than half a century. Over that time, we have grown, embarked on new projects and business ventures, boosted our international presence, and acquired companies with a view to becoming the company we are today.
A company with extensive experience but also with a young spirit and many challenges ahead.
1964
Infarco is founded
A team of pharmacists set up Infarco, the parent company of Cinfa.
1969
Cinfa is born
Based at its first manufacturing plant in Berrioplano (Navarre, Spain), it began to produce non-prescription drugs such as Respibien (oxymetazoline).
1973
Orthopaedics and mobility
We launched a new line of business in the field of orthopaedics and mobility under the Farmalastic brand.
1981
We relocate
We moved to a new manufacturing plant with increased production capacity in Huarte (Navarre, Spain).
1994-1998
Commitment to generic medicines
This decision was to define the future of Cinfa. We embarked on the generic medicines adventure at a time when this was practically an unknown sector in Spain. After four years of development, we launched our first generic drugs in 1998: Ranitidina and Diclofenaco.
2000
New frontiers
We launched our international strategy by entering the Latin American market and then venturing into the Middle East, Africa and Asia.
Latin America
- 2000 Panama
- 2020 Costa Rica
- 2021 Guatemala, El Salvador
- 2022 Honduras
- 2023 Peru
Middle East
- 2013 United Arab Emirates
- 2014 Kuwait
- 2017 Qatar
- 2018 Saudi Arabia
Asia
- 2012 Hong Kong
- 2019 Vietnam
2008
Oncology and transplants
We began developing and producing highly specialised generic medicines for such fields as oncology and transplants. This required us to open a second industrial plant in Olloki (also in Navarre).
2010
Joining the skincare sector
We developed the new line of skin pharmacy products from Cinfa, Be+, including various skin treatments.
2011
First Spanish pharmaceutical laboratory
We achieved leadership in terms of the number of medicines dispensed at Spanish pharmacies. We have maintained that position ever since.
2012
Personalised nutrition
We continued to implement our diversification strategy by launching a new line of nutrition solutions: Ns Nutritional System.
2017
Consumer Healthcare Europe
Cinfa concludes a triple deal to acquire three new companies: Natural Santé, Sakura Italia and Orliman. This strengthens our business in the self-care sector and boosts our presence in southern Europe.
2019
50th anniversary
Cinfa celebrates 50 years of service to healthcare. Half a century of history, following which we have consolidated our position as the leading laboratory in the Spanish pharmaceutical sector, both in terms of units and values.
2024
Nave Neo
We opened our new medicine development, production and distribution depot. Based on the Industry 4.0 concept and equipped with the latest technology, it will allow us to double our medicine production capacity.
